Opportunities, challenges, and caveats of successful molecular imaging of cardiovascular diseases Bodo Levkau EDITORIAL 07 March 2008 Pages: 79 - 81
Cardiovascular diseases as target for imaging Kristof GrafMichael GräfeEckart Fleck EDITORIAL 07 March 2008 Pages: 82 - 86
MR-optical imaging of cardiovascular molecular targets Matthias NahrendorfDavid E. SosnovikRalph Weissleder REVIEW 07 March 2008 Pages: 87 - 94
Annexin A5: an imaging biomarker of cardiovascular risk Edward M. LauferChris P. M. ReutelingspergerLeonard Hofstra REVIEW 07 March 2008 Pages: 95 - 104
Imaging of stem cells using MRI Dara L. KraitchmanJeff W. M. Bulte REVIEW 07 March 2008 Pages: 105 - 113
Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications David E. SosnovikMatthias NahrendorfRalph Weissleder REVIEW 07 March 2008 Pages: 122 - 130
18F-labelled cardiac PET tracers: selected probes for the molecular imaging of transporters, receptors and proteases Klaus KopkaOtmar SchoberStefan Wagner REVIEW 07 March 2008 Pages: 131 - 143
Near-infrared fluorescent probes for imaging vascular pathophysiology Jan KlohsAndreas WunderKai Licha REVIEW 07 March 2008 Pages: 144 - 151
Structural and functional imaging by MRI René M. BotnarEike Nagel REVIEW 07 March 2008 Pages: 152 - 160
Imaging of the heart with computed tomography Thomas G. FlohrBernd M. Ohnesorge REVIEW 07 March 2008 Pages: 161 - 173
Optical imaging of vascular pathophysiology Andreas WunderJan Klohs REVIEW 07 March 2008 Pages: 182 - 190
Combined imaging of molecular function and morphology with PET/CT and SPECT/CT: Image fusion and motion correction Klaus P. SchäfersLars Stegger REVIEW 07 March 2008 Pages: 191 - 199
The future of molecular imaging in the clinic needs a clear strategy and a multidisciplinary effort M. Schäfers OUTLOOK 07 March 2008 Pages: 200 - 202